Dark

NVAX
Novavax Inc
stock NASDAQ

At Close

Jun 16, 2025 3:59:57 PM EDT

7.03USD+1.297%(+0.09)4,590,283

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 16, 2025 9:27:30 AM EDT

7.05USD+1.585%(+0.11)31,638

After-hours

Jun 16, 2025 4:48:30 PM EDT

7.03USD0.000%(0.00)16,999

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

02:02PM EST Novavax Submits Request To U.S. FDA For Emergency Use Authorization Of COVID-19 Vaccine RTTNews

01:44PM EST Novavax Says NVX-COV2373 Demonstrated Overall Efficacy Of ~90% In Prevent-19 Clinical Trial Conducted During Emergence Of Variant Strains Benzinga

01:43PM EST Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of PR Newswire

11:03AM EST Novavax Whale Trades Spotted Benzinga

Jan 28, 2022

08:13AM EST Biotechnology company Novavax, Inc. (NVAX) and Israel's Ministry of Health today announced Friday an agreement for the purchase of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M adjuvant. The Novavax vaccine would be the first protein-based alternative available in Israel. RTTNews

08:03AM EST Novavax And Israel Announce Purchase Agreement For Supply Of COVID-19 Vaccine RTTNews

08:03AM EST Novavax And Israel Ministry Of Health Announce Advance Purchase Agreement For Supply Of COVID-19 Vaccine; Co. To Provide Initial 5M Doses With Option For Additional 5M Doses Benzinga

08:01AM EST Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 PR Newswire

06:17AM EST Israel's Health Ministry Says Signed Deal With Novavax to Buy Covid-19 Vaccine, Pending Regulatory Approval Benzinga

Jan 25, 2022

05:09AM EST Germany to Receive 3.8M Doses of Novavax's COVID-19 Vaccine in Q1 Benzinga

Jan 24, 2022

01:31PM EST Looking At Novavax's Recent Whale Trades Benzinga

Jan 21, 2022

10:05AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022 Benzinga

07:07AM EST Cowen & Co. Initiates Coverage On Novavax with Outperform Rating, Announces Price Target of $150 Benzinga

Jan 20, 2022

08:28AM EST The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug Benzinga

01:11AM EST Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine Benzinga

Jan 19, 2022

09:47PM EST Novavax Inc. (NVAX) said that Australia's Therapeutic Goods Administration or TGA has granted approval for provisional registration of NVX-CoV2373, Novavax' COVID-19 vaccine (adjuvanted), for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The vaccine will be supplied to Australia under the brand name Nuvaxovid. RTTNews

06:41PM EST Australia Therapeutic Goods Administration Grants Provisional Registration For Novavax COVID-19 Vaccine RTTNews

06:22PM EST Australia Therapeutic Goods Administration (TGA) Grants Provisional PR Newswire

03:05PM EST This Is What Whales Are Betting On Novavax Benzinga

Jan 18, 2022

11:39AM EST WHO Chief Scientist Soumya Swaminathan Says There Is No Evidence Right Now That Healthy Children, Healthy Adolescents Need COVID-19 Boosters Benzinga

10:13AM EST EU Regulator Says No Evidence Seen Yet To Recommend 4th Dose Of COVID-19 Vaccines Benzinga

Jan 12, 2022

01:01PM EST Novavax European Commission Doc Shows Co. Received European Union Marketing Authorization For Its COVID-19 Vaccine Benzinga

10:40AM EST Novavax's COVID-19 Vaccine Gets OK In South Korea Benzinga

06:21AM EST Covid-19 vaccine maker Novavax, Inc. (NVAX) and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, announced Wednesday that South Korea's Ministry of Food and Drug Safety or MFDS has approved Novavax COVID-19 Vaccine Nuvaxovid. RTTNews

06:08AM EST Novavax And SK Bioscience Announce South Korea Ministry Of Food And Drug Safety Has Approved A Biologics License Application From SK Bioscience For Nuvaxovid COVID-19 Vaccine Benzinga

06:02AM EST South Korea Ministry Of Food And Drug Safety Approves Novavax COVID-19 Vaccine Nuvaxovid RTTNews

06:01AM EST South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine PR Newswire

05:04AM EST South Korea Authorized Novavax COVID-19 Vaccine Benzinga

Jan 11, 2022

02:44PM EST Shares of vaccine makers are trading lower. The move is possibly due to a rotation into tech stocks, which gained amid a drop in yields. Benzinga

10:38AM EST Novavax Whale Trades Spotted Benzinga

Jan 10, 2022

11:31PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

01:41PM EST Novavax CEO Says Combined Flu/COVID Shot Data Seen In Couple Months Benzinga

01:35PM EST Watching Novavax; Hearing CNBC Now On Bloomberg TV Benzinga

09:47AM EST Novavax Executive Says Co Is Well-Prepared With A Solid EUA Application For COVID-19 Vaccine, Says Expects Response From U.S. FDA In Feb. Benzinga

09:10AM EST Novavax Says Initial 27M Dose Order For COVID-19 Vaccine From EU To Be Shipped In Q1 Was Expanded To Include 42M More Doses To Be Delivered In Q2 Benzinga

09:00AM EST Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP GlobeNewswire Inc

08:55AM EST Novavax, Serum File For Emergency Use Authorization Of RTTNews

08:49AM EST Novavax Files In India For Emergency Use Authorization Of COVID-19 Vaccine Benzinga

08:42AM EST Novavax Files In India For Emergency Use Authorization Benzinga

08:41AM EST Serum Institute Of India File For Emergency Use Authorization Of Novavax' COVID-19 Vaccine In South Africa RTTNews

08:40AM EST Novavax and Serum Institute of India File for Emergency Use Authorization of PR Newswire

Jan 8, 2022

01:04PM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

Jan 7, 2022

10:22PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

08:00PM EST NOVAVAX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX Business Wire

Jan 6, 2022

02:06PM EST This Is What Whales Are Betting On Novavax Benzinga

01:03AM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

Jan 5, 2022

12:38AM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

Jan 4, 2022

04:02PM EST Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference PR Newswire

03:12PM EST SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

Jan 3, 2022

10:32PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

01:55PM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

Jan 1, 2022

09:50AM EST Investors of Novavax, Inc. That A Securities Fraud Class Action Lawsuit Has Been Filed on Their Behalf PR Newswire

Dec 31, 2021

10:00PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

01:49PM EST Novavax Submits Final Data Packages To FDA As Prerequisite To EUA Application Request For COVID-19 Vaccine RTTNews

12:15PM EST Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency PR Newswire

Dec 30, 2021

10:12PM EST FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of PR Newswire

11:47AM EST 'F.D.A. Is Said to Be Near Allowing Boosters for 12- to 15-Year-Olds' -New York Times Report Benzinga

10:17AM EST This Industry Grew During Covid, Against All Odds: Here's Why You Should Consider Investing Benzinga

Dec 28, 2021

11:29PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

11:03AM EST Novavax Whale Trades For December 28 Benzinga

10:43AM EST Novavax Up 11% On Receiving Authorization For Covovax In India RTTNews

09:44AM EST The Drugs Controller General of India has granted emergency use authorization for Novavax Inc's (NVAX) recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M adjuvant. The vaccine will be manufactured and marketed in India by Serum Institute of India Pvt. Ltd or SII under the brand name Covovax, Novavax said in a statement. RTTNews

09:31AM EST Novavax, Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In India RTTNews

09:30AM EST Novavax Confirms Earlier Reports Co, Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In India Benzinga

09:30AM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

09:30AM EST Novavax and Serum Institute of India Receive Emergency Use Authorization for PR Newswire

Dec 27, 2021

10:51PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

03:55PM EST SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

12:25PM EST 'CDSCO panel recommends emergency use authorization for SII's Covid vaccine Covovax' -Times Of India. NOTE: Covovax Is Produced By SII Under License From Novavax Benzinga

11:17AM EST NVAX Reminder: Kessler Topaz Meltzer & Check, LLP - January 11, GlobeNewswire Inc

Dec 24, 2021

05:56AM EST Novavax Inc. (NVAX) and SK bioscience Co. Limited, a vaccine business subsidiary of Korea-based SK Group, said that they expanded their collaboration and license agreements for NVX-CoV2373, Novavax' recombinant nanoparticle protein-based COVID-19 vaccine. RTTNews

Dec 23, 2021

07:25PM EST NVAX CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces to PR Newswire

06:30PM EST Novavax and SK bioscience Expand Manufacturing Agreement PR Newswire

12:13PM EST UK Says COVID Omicron Variant Hospital Risk 50-70% Lower Than Compared To Delta Variant Benzinga

11:18AM EST 'New Jersey reports more than 15,000 new COVID cases, more than double the pre-omicron record and up almost 60% in just one day' -Tweet From NBC New York Benzinga

10:15AM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

08:00AM EST Benzinga Pro's Top 5 Stocks To Watch For Thursday, Dec. 23, 2021 (Happy Holidays! Edition): NVAX, CROX, ADTH, KXIN, ALLK Benzinga

07:29AM EST The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review Benzinga

05:56AM EST U.S. Equity Futures Higher Ahead of Christmas Weekend; Positive News on Effectiveness of Vaccines Against Omicron Variant Benzinga

05:23AM EST A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Data Benzinga

Dec 22, 2021

11:51PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

05:41PM EST Shares of Novavax, Inc. (NVAX) gained over 5% in extended trading session on Wednesday after the biotechnology company announced that data from its ongoing Phase 2 boost study of Covid-19 vaccine demonstrated "strong immune responses" against the Omicron variant and other circulating variants of the coronavirus. RTTNews

04:19PM EST Novavax shares were trading lower after the company reported initial data evaluating the immune response of its COVID-19 vaccine, NVX-CoV2373, against the omicron variant as well as additional data from its ongoing Phase 2 boost study. Benzinga

04:04PM EST UPDATE: Novavax Says 'Development of Omicron-specific vaccine on track for initiation of GMP manufacturing in early January' Benzinga

04:03PM EST UPDATE: Novavax Says 'Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron, other variants ; Third dose produced increased immune responses comparable...' Benzinga

04:02PM EST Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine PR Newswire

04:02PM EST Novavax Reports Initial Omicron Cross-Reactivity Data From COVID Vaccine Booster, Adolescents Studies Benzinga

03:54PM EST 'New York reports 28,924 new coronavirus cases, the biggest one-day increase on record, of which 17,221 are in New York City' -Tweet From BNO Newsroom Benzinga

03:35PM EST White House Advisor Dr. Fauci Says Attending Large Gatherings Of 40+ People Is Not Considered Safe For Vaccinated, Boosted People Benzinga

11:22AM EST Study Out Of Scotland Shows Risk Of Hospital Admission For Patients With COVID Omicron Variant Reduced By 2/3 vs Delta Variant Benzinga

08:13AM EST Novavax Initiates Phase 3 COVID-19 Vaccine Booster Study Benzinga

07:42AM EST The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda Benzinga

05:38AM EST U.S. Equity Futures Lower, European Markets Mixed; Governments Across the World Tighten Restrictions Due to Omicron Surge; Tech Companies Cancel Out of CES Vegas Event Benzinga

Dec 21, 2021

11:32PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

08:56PM EST Novavax (NVAX) said Tuesday that the WHO Strategic Advisory Group of Experts on Immunization or SAGE has recommended primary two-dose vaccination series of its COVID-19 vaccine NVX-CoV2373 in persons aged 18 and older. The panel of experts also recommended additional third dose of NVX-CoV2373 administered to immunocompromised persons. RTTNews

08:22PM EST Novavax Inc. (NVAX) announced initiation of PREVENT-19 COVID-19 vaccine phase 3 trial booster study. RTTNews

06:42PM EST Novavax Announces Initiation Of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study RTTNews

05:09PM EST Novavax Reports Initiation Of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study Benzinga

05:01PM EST Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial PR Newswire

04:59PM EST UPDATE: Novavax WHO Panel Says Recommends Primary 2-Dose Vaccination Series Of Co.'s Vaccine, Also Recommends Added 3rd Dose To Immunocompromised Persons Benzinga

04:59PM EST Novavax Highlights WHO Strategic Advisory Group Of Experts On Immunization Published Interim Recommendations For Use Of NVX-CoV2373 Benzinga

04:44PM EST World Health Organization SAGE Issues Interim Recommendations for Novavax PR Newswire

03:36PM EST 'Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers.' -Israel Reporter Tweet Benzinga

11:41AM EST Novavax CEO Says Will Have Data On Efficacy Against Omicron Variant Benzinga

10:24AM EST NYC Mayor's Office Tweets '@NYCMayor just announced a new $100 incentive for New Yorkers if they get their booster shot at City-run sites before December 31.' Benzinga

10:22AM EST This Is What Whales Are Betting On Novavax Benzinga

09:58AM EST JP Morgan Maintains Neutral on Novavax, Raises Price Target to $209 Benzinga

06:49AM EST U.S, Equity Futures, European Markets Higher; Moderna on Monday Said Booster Dose Appears Effective vs Omicron; President Biden Promising 500M Free At-Home Covid Tests Benzinga

Dec 20, 2021

11:00PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

03:20PM EST Novavax Shares Quiet Following Co. CEO Comment Co. Will Be Able To Produce 2B COVID-19 Vaccine Doses During Q1'22 Benzinga

02:43PM EST Novavax's COVID-19 Vaccine Scores Conditional Approval In Europe Benzinga

12:22PM EST Novavax Confirms Earlier Report WHO Grants Second Emergency Use Listing For Co's COVID-19 Vaccine Benzinga

12:20PM EST World Health Organization Grants Second Emergency Use Listing for Novavax PR Newswire

11:02AM EST Novavax Whale Trades Spotted Benzinga

11:00AM EST European Commission Grants Conditional Marketing Authorization for Novavax PR Newswire

10:03AM EST Novavax shares were trading higher on a report the company is expected to start delivering Covid-19 shots to EU states in Q1 2022 if the EU drug regulator gives approval. Benzinga

10:01AM EST Novavax shares were trading higher after the company announced the European Medicines Agency recommended granting a conditional marketing authorization for its COVID-19 vaccine to prevent COVID-19 in people 18 years of age and older. Benzinga

09:34AM EST Novavax shares are trading higher on a report the company is expected to start delivering Covid-19 shots to EU states in Q1 2022 if the EU drug regulator gives approval. Benzinga

08:44AM EST Biotechnology company Novavax, Inc. (NVAX) announced Monday that the European Medicines Agency (EMA) has recommended granting a conditional marketing authorization for Novavax' COVID-19 vaccine (NVX-CoV2373) to prevent COVID-19 in people from 18 years of age and older. RTTNews

08:41AM EST EMA Head Says COVID Vaccines Clearly Less Effective Against Omicron; Says Data On Omicron Not At All Definitive But It's Clear That There Is A Drop In Vaccine Effectiveness Benzinga

08:28AM EST Novavax Receives Positive EMA Recommendation For Conditional Marketing Authorization Of COVID-19 Vaccine RTTNews

08:26AM EST Novavax Announces European Medicines Agency Has Recommended Granting A Conditional Marketing Authorization For Novavax' COVID-19 Vaccine Benzinga

08:25AM EST Novavax Receives Positive European Medicines Agency Recommendation for PR Newswire

07:25AM EST The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.10 A.M. ET). RTTNews

06:05AM EST Novavax Expected to Start Delivering Covid-19 Shots to EU States in Q1 2022 if EU Drug Regulator Gives Approval Benzinga

05:28AM EST U.S. Equity Futures, European Markets Fall Sharply Over Rising Omicron Concerns; Two U.S. Senators Test Positive for Covid-19; Moderna Said Booster Effective vs Omicron; Senator Manchin Says he Will Not Support Biden Spending Bill Benzinga

Dec 19, 2021

09:04PM EST NVAX INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP GlobeNewswire Inc

07:26PM EST Novavax and Serum Institute of India Announced World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine Benzinga

07:20PM EST New Jersey Democratic Senator Cory Booker Says He Has Tested Positive for Covid-19 Benzinga

05:16PM EST Massachusetts Senator Warren Tests Positive for Covid-19 Benzinga

12:54PM EST The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week Benzinga

Dec 18, 2021

10:38AM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

Dec 17, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

10:39AM EST Novavax, Serum Institute Of India Highlight Earlier News WHO Granted Emergency Use Authorization For NVX-CoV2373 COVID-19 Vaccine Benzinga

10:38AM EST Novavax and Serum Institute of India Announce World Health Organization Grants PR Newswire

08:56AM EST WHO Issues Emergency Use Listing For NVX-CoV2373 COVID-19 Vaccine Benzinga

Dec 16, 2021

08:27PM EST FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of PR Newswire

02:14PM EST WHO, European Medicines Agency Could Approve Novavax COVID-19 Next Week Benzinga

01:57PM EST World Trade Organization Chief Says Parties Getting Close To Solution In Dispute Over COVID-19 Vaccine Rights Benzinga

12:16PM EST CDC Says There Have Been 8 Reports To Vaccine Adverse Event Reporting System That Meet Definition Of Myocarditis Among Children Aged 5-11 Who Received COVID-19 Vaccine Benzinga

12:15PM EST U.S. CDC Says No Confirmed Reports Of Myocarditis In Vaccine Safety Datalink Monitoring System Among Children Aged 5-11 Who Received COVID-19 Vaccine Benzinga

08:20AM EST The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street Benzinga

12:06AM EST Novavax, Inc. (NVAX), a biotechnology company, announced late Wednesday that its the submission of a New Drug Application or NDA in Japan for its COVID-19 vaccine by its partner Takeda Pharmaceutical Co. Ltd. (TKPHF.PK, TAK). RTTNews

Dec 15, 2021

11:52PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

11:14PM EST Novavax Announces Submission NDA In Japan For Approval Of COVID-19 Vaccine By Its Partner Takeda RTTNews

11:02PM EST Novavax Announces Submission of New Drug Application in Japan for Approval of PR Newswire

Dec 14, 2021

10:46PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

09:48PM EST Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm PR Newswire

04:44AM EST India's Serum Institute CEO Said Hopes to Launch Novavax Vaccine for Children in Six Months Benzinga

Dec 13, 2021

11:06PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

02:23PM EST Looking At Novavax's Recent Whale Trades Benzinga

09:30AM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

06:45AM EST Biotechnology company Novavax, Inc. (NVAX) announced Monday that it has submitted a regulatory filing to the Ministry of Health and Prevention (MoHaP) for emergency use of its COVID-19 vaccine in the United Arab Emirates (UAE). RTTNews

06:33AM EST Novavax Files For Emergency Use Of COVID-19 Vaccine In UAE RTTNews

06:32AM EST Novavax Files For Emergency Use Of COVID-19 Vaccine In The United Arab Emirates Benzinga

Dec 11, 2021

09:08PM EST Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action GlobeNewswire Inc

Dec 10, 2021

10:50PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

Dec 9, 2021

09:42PM EST 'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report Benzinga

Dec 8, 2021

11:34PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

Dec 7, 2021

11:12PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

05:15PM EST SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

01:03PM EST Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response Benzinga

11:56AM EST What Are Whales Doing With Novavax Benzinga

Dec 6, 2021

10:26PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

04:35PM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

01:50PM EST CNN Reporter Tweets 'Good news on Omicron and vaccines: "The early indication is that you are going to be protected against serious illness with two doses of mRNA-containing vaccines. And the booster dose can increase antibodies,"' Benzinga

Dec 5, 2021

09:18AM EST January 11, 2022 Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm PR Newswire

09:15AM EST CDC Director Walensky Said Omicron Covid-19 Cases Found in at Least 15 U.S. States; Said Delta Variant of Covid-19 Still Makes Up Majority of U.S. Cases Benzinga

Dec 3, 2021

10:50PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

01:08PM EST NVAX DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds GlobeNewswire Inc

Dec 2, 2021

01:53PM EST President Biden Says Team Is Working With Vaccine Firms For Contingency Plan For Vaccines, Boosters Benzinga

12:01PM EST This Is What Whales Are Betting On Novavax Benzinga

09:40AM EST Novavax Initiates Development Of Omicron-Specific Vaccine Construct Benzinga

Dec 1, 2021

10:59PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

07:28PM EST CLAIMSFILER ALERTS NOVAVAX Investors to Lead Plaintiff Deadline in Class Action PR Newswire

07:18AM EST WHO Official Says Some of the Early Indications Is That Most Omicron Cases Are Mild, No Severe Cases Benzinga

05:45AM EST Norway Detected First Two Cases of Omicron Covid Variant Benzinga

05:11AM EST Japan Confirmed Second Case of Omicron Variant of the Covid-19 on Wednesday Benzinga

05:00AM EST Israel's Health Minister Nitzan Horowitz Said Individuals Fully Vaccinated Against Corona Within Six Months or With the Booster are Protected Against the Omicron Variant Benzinga

Nov 30, 2021

11:26PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

06:27PM EST SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

04:42PM EST Two Israeli Doctors Infected with Omicron Variant Benzinga

04:40PM EST China Xinhua News Says No Omicron Cases Reported on Chinese Mainland So Far Benzinga

04:39PM EST U.S. Equity Futures, European Markets Fall Following Moderna CEO Comments on Vaccines Likely Less Effectiveness Against Omicron Variant Benzinga

04:39PM EST Dutch Authorities Said Omicron Variant Was Detected in the Netherlands on Nov. 19, Before S. Africa Flights Benzinga

04:39PM EST Moderna CEO Said in Financial Times Interview Vaccines are Likely Less Effective against Omicron; Said Mutations Mean Existing Vaccines Likely Need Modifying Benzinga

04:23PM EST 'Novavax Vaccine Filing Guidance Unchanged, Spokeswoman Says' - Tweet By Zach Biotech Benzinga

04:07PM EST Novavax shares were trading higher amid the Omicron COVID-19 variant. Benzinga

Nov 29, 2021

10:49PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

04:38PM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

06:29AM EST 'Technical paper on the #COVID19 variant of concern, Omicron. It includes a set of preparedness actions for countries' - World Health Organization Benzinga

06:26AM EST World Health Organization Tweeted Earlier "We don't yet know whether Omicron is associated with more: -transmission -severe #COVID19 disease -risk of reinfections -risk of evading vaccines. Scientists at WHO & around the Benzinga

05:58AM EST Italy's Radiocor Says Italy Reported Four Omicron Variant Cases Benzinga

Nov 28, 2021

05:07PM EST NIH Director Collins Said Current Vaccinations Likely to Protect Against Omicron Benzinga

09:14AM EST National Institute of Allergy and Infectious Diseases Director Fauci Tells ABC News Too Early to Say if We Need New Lockdowns or Mandates Benzinga

Nov 27, 2021

09:23AM EST Two cases of Omicron Variant Detected in UK: Individuals in Chelmsford and Nottingham had Traveled to Southern Africa Benzinga

Nov 26, 2021

01:27PM EST Novavax Said Recent Data From Phase 2 Trial Lead Us to Believe That Our Vaccine Is Likely to Provide Protection Against New, Emerging Covid-19 Variants Benzinga

10:03AM EST Novavax, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm PR Newswire

05:43AM EST France, Czech Republic, Singapore Among Countries Reported to Restrict Travel from Southern Africa Due to "Nu" Variant Benzinga

05:15AM EST Total of 84 Confirmed Cases of COVID-19 Variant B.1.1.529 With 77 in S. Africa, 4 in Botswana, 2 in Hong Kong, 1 in Israel Benzinga

05:12AM EST U.S. Equity Futures Sharply Lower; Covid-Related Stocks Surge on Reports of New, Heavily-Mutated Strain, Feared to be More Infectious than Delta Variant Benzinga

05:09AM EST Israeli, Who Returned from Malawi, Tested Positive for New Highly-Mutated Covid-19 Strain Reported in S. Africa Benzinga

Nov 25, 2021

08:50AM EST Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder GlobeNewswire Inc

Nov 24, 2021

11:34PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

12:47PM EST Looking At Novavax's Recent Whale Trades Benzinga

08:55AM EST Biotechnology company Novavax, Inc. (NVAX) announced Wednesday its submission to the Singapore Health Sciences Authority (HSA) for interim authorization of its COVID-19 vaccine under the Pandemic Special Access Route (PSAR). RTTNews

08:31AM EST Novavax Files For Interim Authorization Of COVID-19 Vaccine In Singapore RTTNews

12:05AM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

Nov 23, 2021

09:22AM EST Novavax To Participate In Evercore ISI's HealthCONx Conference Dec. 2 At 9:15 a.m. EST Benzinga

09:16AM EST Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual PR Newswire

Nov 22, 2021

10:39PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

02:47PM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

Nov 19, 2021

10:00PM EST ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

09:44PM EST Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of PR Newswire

12:02PM EST Novavax Whale Trades Spotted Benzinga

Nov 18, 2021

11:26PM EST FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of PR Newswire

06:29PM EST SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with GlobeNewswire Inc

02:33PM EST India's Government Has No Plans Yet To Buy Merk's COVID Pills; Approves 20M Novavax Vaccine Dose Order Benzinga

Nov 17, 2021

11:50PM EST Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: GlobeNewswire Inc

12:12PM EST What Are Whales Doing With Novavax Benzinga

10:50AM EST Why Novavax Shares Are Rising Benzinga

09:32AM EST with Significant Losses to Contact Firm's Attorneys Now, Securities Class Action Filed PR Newswire

09:29AM EST Novavax Confirms EMA Review Of COVID-19 Vaccine Filing For Conditional Marketing Authorization RTTNews

09:27AM EST Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing PR Newswire

09:27AM EST Novavax Confirms European Medicines Agency Review Of COVID-19 Vaccine Filing For Conditional Marketing Authorization Benzinga

08:51AM EST Novavax Inc. (NVAX) and Serum Institute of India Pvt. Ltd. said that the Philippine Food and Drug Administration has granted emergency use authorization for Novavax' recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M adjuvant. The vaccine will be manufactured and marketed in the Philippines by Serum Institute of India under the brand name COVOVAX. RTTNews

08:28AM EST Novavax, Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In Philippines RTTNews

08:27AM EST Novavax, Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In The Philippines Benzinga

08:26AM EST Novavax and Serum Institute of India Receive Emergency Use Authorization for PR Newswire

Nov 16, 2021

10:34PM EST The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. GlobeNewswire Inc

11:11AM EST Gainey McKenna & Egleston announces that a class action lawsuit has been filed against of Novavax, Inc. (Novavax or the Company) (NASDAQ: NVAX) in the United States District Court for the District of Maryland on behalf of those who purchased Novavax common stock between March 2, 2021 and October 19, 2021, inclusive (the Class Period). GlobeNewswire Inc

Nov 15, 2021

12:51PM EST Watching Shares Of Novavax; Adage Capital Takes Stake Of 10K Shares In Co Benzinga

11:10AM EST Novavax Reports Submission Of Its Biologics License Application In South Korea For Approval Of NVX-CoV2373 Benzinga

09:34AM EST Novavax Inc. (NVAX) said that SK bioscience has summited a biologics license application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate, to South Korea's Ministry of Food and Drug Safety. RTTNews

08:48AM EST Novavax : SK Bioscience Submits Application For NVX-CoV2373, COVID-19 Vaccine Candidate, To South Korea's MFDS RTTNews

08:45AM EST Novavax Announces Submission of Biologics License Application in South Korea PR Newswire

Nov 12, 2021

11:38PM EST Pomerantz Law Firm Announces the Filing of a Class Action Against GlobeNewswire Inc

Nov 9, 2021

09:36AM EST Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. GlobeNewswire Inc

Nov 5, 2021

09:43AM EDT The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill Benzinga

09:32AM EDT Why Novavax Shares Are Rising During Thursday's After-Hours Session Benzinga

09:31AM EDT Recap: Novavax Q3 Earnings Benzinga

09:28AM EDT Novavax Expects To Have Vaccine Capacity In Excess Of 2B Annual Doses In 2022 Benzinga

09:28AM EDT Novavax Q3 EPS $(4.31) Misses $(3.91) Estimate, Sales $178.84M Miss $334.62M Estimate Benzinga

09:20AM EDT Novavax Files COVID-19 Vaccine For Emergency Use Listing With World Health Organization Benzinga

Nov 4, 2021

04:12PM EDT Novavax Q3 Loss/share $4.31 Vs. Loss $3.21 Year Ago RTTNews

04:05PM EDT Novavax Files COVID-19 Vaccine For Emergency Use Listing With WHO RTTNews

04:02PM EDT Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights PR Newswire

04:02PM EDT Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health PR Newswire

11:40AM EDT Why Novavax Shares Are Falling Benzinga

document.getElementById("G3Y5SK").onerror = function(){this.style.display='none';}; .dark-mode .HH7hqN{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .HH7hqN{ color: #333333; background-color: white; border: 2px solid #333333; }NVAXNovavax Incstock NASDAQ

NVAX
Novavax Inc
stock NASDAQ